F
Frank Williams
Researcher at United States Department of the Navy
Publications - 3
Citations - 234
Frank Williams is an academic researcher from United States Department of the Navy. The author has contributed to research in topics: Postmarketing surveillance & Pharmacovigilance. The author has an hindex of 3, co-authored 3 publications receiving 218 citations.
Papers
More filters
Journal ArticleDOI
Guidelines for Submitting Adverse Event Reports for Publication
William Kevin Kelly,Felix M. Arellano,Joanne Barnes,Ulf Bergman,Ralph Edwards,Alina M. Fernandez,Stephen B. Freedman,David I. Goldsmith,Kui A. Huang,Judith K. Jones,Rachel McLeay,Nicholas Moore,Rosie H. Stather,Thierry Trenque,William G. Troutman,Eugène van Puijenbroek,Frank Williams,Robert P. Wise +17 more
TL;DR: Based on a literature review and collective experience in reviewing adverse event case reports in regulatory, academic, and industry settings, information that is proposed should always be considered for inclusion in a report submitted for publication is identified.
Journal ArticleDOI
Guidelines for submitting adverse event reports for publication
William N. Kelly,Felix M. Arellano,Joanne Barnes,Ulf Bergman,Ralph Edwards,Alina M. Fernandez,Stephen B. Freedman,David I. Goldsmith,Kui A. Huang,Judith K. Jones,Rachel McLeay,Nicholas Moore,Rosie H. Stather,Thierry Trenque,William G. Troutman,Frank Williams,Robert P. Wise,Victor Segalen +17 more
TL;DR: These guidelines have been endorsed by the International Society for Pharmacoepidemiology (ISPE) and the International society of Pharmacovigilance (ISoP) and are freely available on the societies' web sites and widespread distribution is encouraged.
Journal ArticleDOI
Guidelines for submitting adverse event reports for publication
William Kevin Kelly,Felix M. Arellano,Joanne Barnes,Ulf Bergman,Ralph Edwards,Alina M. Fernandez,Stephen B. Freedman,David I. Goldsmith,Kui A. Huang,Judith K. Jones,Rachel McLeay,Nicholas Moore,Rosie H. Stather,Thierry Trenque,William G. Troutman,Eugène van Puijenbroek,Frank Williams,Robert P. Wise +17 more
TL;DR: Information is proposed that should always be considered for inclusion in a report submitted for publication that is based on a literature review and collective experience in reviewing adverse event case reports in regulatory, academic and industry settings.